What is the prevalence of Bronchiectasis?

The prevalence of bronchiectasis is estimated to range from 50 to 500 cases per 100,000 individuals globally, though these figures vary significantly by region, age, and diagnostic criteria.

Epidemiological Landscape

While bronchiectasis is not classified as a single "rare" disease in some regions—often being considered a chronic respiratory condition—the prevalence of non-cystic fibrosis bronchiectasis is increasing worldwide. Incidence rates are difficult to pinpoint precisely because the condition is frequently underdiagnosed or misdiagnosed as chronic obstructive pulmonary disease (COPD) or asthma. Data from the European Lung Foundation and recent systematic reviews suggest that the burden of bronchiectasis is rising, particularly in aging populations.

Demographics and Variations

Research indicates a clear gender disparity, with bronchiectasis being more frequently diagnosed in females than in males. Regarding age, while it can present in childhood—often linked to primary ciliary dyskinesia or post-infectious complications—the prevalence increases dramatically with age, peaking in individuals over the age of 70. Geographic and ethnic variations are substantial; higher rates are often observed in Indigenous populations (such as in New Zealand, Australia, and Alaska), which researchers attribute to a combination of genetic susceptibility and socioeconomic factors impacting early-life respiratory health.

Data Challenges and Real-World Perspectives

The primary challenge in determining the true prevalence of bronchiectasis lies in the lack of standardized screening and the reliance on high-resolution computed tomography (HRCT) for diagnosis, which may not be accessible in all healthcare settings. At DiseaseMaps.org, our community of 350 members provides a vital, complementary perspective. By sharing lived experiences, our members help us understand the diagnostic journey and the impact of the condition, bridging the gap between clinical statistics and the daily reality of those managing the disease.

Medical Disclaimer: This information is for educational purposes and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

References

• Orphanet (ORPHA: 61834): Bronchiectasis


• NIH Genetic and Rare Diseases Information Center (GARD): Bronchiectasis


• European Lung Foundation: Bronchiectasis Patient Priorities and Epidemiology Data